B. Metzler Seel. Sohn & Co. Ag Teva Pharmaceutical Industries LTD Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.65 Billion
- Q1 2025
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 76,244 shares of TEVA stock, worth $1.29 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
76,244
Previous 76,244
-0.0%
Holding current value
$1.29 Million
Previous $1.68 Million
30.3%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding TEVA
# of Institutions
659Shares Held
626MCall Options Held
27.9MPut Options Held
21.8M-
Black Rock Inc. New York, NY43MShares$728 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E939MShares$661 Million39.53% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$640 Million5.98% of portfolio
-
Menora Mivtachim Holdings Ltd.29.2MShares$494 Million2.92% of portfolio
-
Exor Capital LLP London, X027.9MShares$472 Million12.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.8B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...